[Treatment of hypercholesterolemia in kidney transplant recipients].
Fritsche
L
L
Med. Klinik mit Schwerpunkt Nephrologie, Charité Campus Mitte, Berlin. Lutz.Fritsche@charite.de
Budde
K
K
Neumayer
H-H
HH
D001189:Aryl Hydrocarbon Hydroxylases / Q000378:metabolism; D002318:Cardiovascular Diseases / Q000209:etiology / Q000517:prevention & control*; D016572:Cyclosporine / Q000494:pharmacology / Q000627:therapeutic use; D051544:Cytochrome P-450 CYP3A; D004347:Drug Interactions; D005229:Fatty Acids, Monounsaturated / Q000009:adverse effects / Q000493:pharmacokinetics / Q000627:therapeutic use; D000077340:Fluvastatin; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000009:adverse effects / Q000493:pharmacokinetics / Q000627:therapeutic use*; D006937:Hypercholesterolemia / Q000188:drug therapy* / Q000209:etiology; D007166:Immunosuppressive Agents / Q000494:pharmacology / Q000627:therapeutic use; D007211:Indoles / Q000009:adverse effects / Q000493:pharmacokinetics / Q000627:therapeutic use; D016030:Kidney Transplantation / Q000009:adverse effects*; D010089:Oxidoreductases, N-Demethylating / Q000378:metabolism; D011322:Primary Prevention; D012307:Risk Factors
D005229:Fatty Acids, Monounsaturated; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D007166:Immunosuppressive Agents; D007211:Indoles; D000077340:Fluvastatin; D016572:Cyclosporine; D001189:Aryl Hydrocarbon Hydroxylases; D051544:Cytochrome P-450 CYP3A; D010089:Oxidoreductases, N-Demethylating
Behandlung der Hypercholesterinämiebei Nierentransplantierten.